[go: up one dir, main page]

ECSP088489A - SULFAMOIL SULFONATE PRODUCTS - Google Patents

SULFAMOIL SULFONATE PRODUCTS

Info

Publication number
ECSP088489A
ECSP088489A EC2008008489A ECSP088489A ECSP088489A EC SP088489 A ECSP088489 A EC SP088489A EC 2008008489 A EC2008008489 A EC 2008008489A EC SP088489 A ECSP088489 A EC SP088489A EC SP088489 A ECSP088489 A EC SP088489A
Authority
EC
Ecuador
Prior art keywords
sulfamoil
production
sulfonate products
sulfonate
products
Prior art date
Application number
EC2008008489A
Other languages
Spanish (es)
Inventor
Reinhard Nubbemeyer
Ralf Wyrwa
Ursula Ganzer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ECSP088489A publication Critical patent/ECSP088489A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Esta invención se relaciona con prodrogas de sulfonato de sulfamoilo de fórmula general I, con un proceso para su producción, con composiciones farmacéuticas que contienen estos compuestos, y con su uso para la producción de agentes farmacéuticos disponibles por vía oral.Los compuestos de acuerdo a la invención se unen a anhidrasas carbónicas e inhiben a estas enzimas.This invention relates to sulfamoyl sulfonate prodrugs of general formula I, a process for their production, pharmaceutical compositions containing these compounds, and their use for the production of orally available pharmaceutical agents.The compounds according to The invention binds carbonic anhydrases and inhibits these enzymes.

EC2008008489A 2005-11-30 2008-05-30 SULFAMOIL SULFONATE PRODUCTS ECSP088489A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005057408A DE102005057408A1 (en) 2005-11-30 2005-11-30 New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases

Publications (1)

Publication Number Publication Date
ECSP088489A true ECSP088489A (en) 2008-06-30

Family

ID=37983623

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008489A ECSP088489A (en) 2005-11-30 2008-05-30 SULFAMOIL SULFONATE PRODUCTS

Country Status (15)

Country Link
EP (1) EP1957513A2 (en)
JP (1) JP2009517424A (en)
KR (1) KR20080072956A (en)
CN (1) CN101316858A (en)
AU (1) AU2006319380A1 (en)
BR (1) BRPI0619253A2 (en)
CA (1) CA2632272A1 (en)
CR (1) CR10003A (en)
DE (1) DE102005057408A1 (en)
EA (1) EA200801306A1 (en)
EC (1) ECSP088489A (en)
IL (1) IL191570A0 (en)
NO (1) NO20082915L (en)
WO (1) WO2007062874A2 (en)
ZA (1) ZA200805659B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2411003A4 (en) * 2009-03-24 2012-10-17 Univ Singapore USE OF ARTEMISININE DERIVATIVES FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASE (COPD)
CN101987101A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Anti-inflammatory eye composition with glucocorticoid aromatic sulfamoyl sulfonic acid ester as active ingredient
CN101987104A (en) * 2009-08-05 2011-03-23 天津金耀集团有限公司 Ophthalmic composition of heteroaryl sulfamoyl carboxylic ester carbonic anhydrase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
DE102004025986A1 (en) * 2004-05-21 2005-12-15 Schering Ag Steroid prodrugs with androgenic effects
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs
DE102004025966A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estradiol prodrugs

Also Published As

Publication number Publication date
BRPI0619253A2 (en) 2011-09-27
WO2007062874B1 (en) 2007-09-27
EP1957513A2 (en) 2008-08-20
NO20082915L (en) 2008-06-27
KR20080072956A (en) 2008-08-07
CA2632272A1 (en) 2007-06-07
DE102005057408A1 (en) 2007-05-31
AU2006319380A1 (en) 2007-06-07
EA200801306A1 (en) 2008-10-30
WO2007062874A2 (en) 2007-06-07
ZA200805659B (en) 2009-10-28
WO2007062874A3 (en) 2007-07-12
IL191570A0 (en) 2008-12-29
CN101316858A (en) 2008-12-03
CR10003A (en) 2008-08-21
JP2009517424A (en) 2009-04-30

Similar Documents

Publication Publication Date Title
DOP2006000193A (en) ISOINDOL-IMIDA COMPOUNDS AND COMPOSITIONS INCLUDING THEM AND METHODS FOR USE
UY29919A1 (en) SUBSTITUTED DERIVATIVES OF 3,4-DIHYDROISOQUINOLIN-1-AMINO-TRIFLUOROACETATE, ITS PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
ECSP099044A (en) FUSIONED PYRIMID COMPOUNDS
UY28747A1 (en) NEW PROCESS FOR SYNTHESIS AND NEW CRYSTAL FORM OF AGOMELATINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CR11618A (en) SERINA PROTEASA MACROCYCLIC INHIBITORS
UY30025A1 (en) SUBSTITUTED DERIVATIVES OF 2-AMINO-5,6-DIHIDRO PIRIMIDIN-4 (3H) -ONAS AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND APPLICATIONS.
UY29530A1 (en) CHEMICAL COMPOUNDS
CR10696A (en) ISOINDOL N-METHYLAMINE COMPOUNDS, COMPOSITIONS THAT INCLUDE THEM AND METHODS USING THE SAME
CU20090070A7 (en) NEW DERIVATIVES OF SULFONAMIDE AS ANTAGONISTS OF BRADIQUININA
ECSP077271A (en) PIRIMIDINE DERIVATIVES
PA8796201A1 (en) ANTI-INFECTIVE AGENTS AND THEIR USE
CO6280399A2 (en) PEPTIDIL NITRILOS AND USE OF THE SAME AS INHIBITORS OF PEPTIDIL PEPTIDASA I
ECSP066914A (en) CRYSTAL FORM OF THE IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
ECSP088221A (en) ALFA2C ADRENORECEPTORS AGONISTS
ECSP077259A (en) PIRIMIDINE DERIVATIVES
CU20060037A7 (en) GAMMA CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ECSP078053A (en) NEW DERIVATIVES OF 2-AZETIDINONE USEFUL IN THE TREATMENT OF HYPERLIPIDEMIA CONDITIONS
ECSP088854A (en) VR1 BENCIMIDAZOLIC MODULATORS
CU20060038A7 (en) GAMMA-D CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR062211A1 (en) DERIVATIVES OF 6-CARBOXI-NORMORFINANO. PHARMACEUTICAL COMPOSITIONS
BRPI0712889A8 (en) compound, process for the preparation of a compound, intermediate compound, and, pharmaceutical composition.
ECSP099389A (en) NEW CRYSTAL FORMS
UY29607A1 (en) CHEMICAL COMPOUNDS
AR058348A1 (en) DERIVATIVES OF 1-AZA-BICYCLE-NONANE AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
CR9391A (en) DERIVATIVES OF INDANIL-PIPERAZINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM